The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis

The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis

Introduction: Osteoporosis and sarcopenia are said to be similar disorders. However, few reports have described the effects of anti-osteoporosis drugs on muscle mass in clinical practice. Methods: We selected 150 postmenopausal women with osteoporosis treated by minodronate (osteoporosis medication...

Full description

Bibliographic Details
Main Authors: Kazuki Fujimoto, Kazuhide Inage, Toru Toyoguchi, Yawara Eguchi, Sumihisa Orita, Kazuyo Yamauchi, Miyako Suzuki, Gou Kubota, Takeshi Sainoh, Jun Sato, Yasuhiro Shiga, Koki Abe, Hirohito Kanamoto, Masahiro Inoue, Hideyuki Kinoshita, Masaki Norimoto, Tomotaka Umimura, Masao Koda, Takeo Furuya, Junichi Nakamura, Tsutomu Akazawa, Atsushi Terakado, Kazuhisa Takahashi, Seiji Ohtori
Format: Article
Language:English
Published: The Japanese Society for Spine Surgery and Related Research 2018-04-01
Series:Spine Surgery and Related Research
Subjects:
osteoporosis
sarcopenia
bone mineral density
minodronate
activated vitamin D
muscle mass
postmenopausal
Online Access:https://www.jstage.jst.go.jp/article/ssrr/2/2/2_2017-0016/_pdf/-char/en

Similar Items

Similar Items